Victory Square Health has been granted permission by the Food & Drug Administration (FDA) in the United States to commence marketing, sales and distribution under the emergency use authorization (EUA) for its Safetest 15 Minute Rapid Test Covid-19 assay. Victory Square Health acquired Brazilian Covid19 test developers Safetest in June. The Safetest 15 Minute Covid-19 Rapid Test […]
Victory Square Health
Victory Square Health Receives European Union Approval for COVID-19 Antibody Test
Vancouver’s Victory Square Health has been granted approval in the European Union to commence marketing, sales and distribution for its Safetest ELISA Covid-19 antibody test. Victory Square Health acquired Brazilian Covid19 test developers Safetest in June. The European Union approval comes on the heels of Safetest being granted permission by the Food & Drug Administration […]
Victory Square Health Receives Brazil’s Approval for COVID-19 Antibody Test
Vancouver’s Victory Square Health has been granted approval by the Brazilian Health Regulatory Agency to commence marketing, sales and distribution for its Safetest ELISA Covid-19 antibody test. Victory Square Health acquired Brazilian Covid19 test developers Safetest in June. The Brazilian approval comes on the heels of Safetest being granted permission by the Food & Drug […]
Victory Square Gets FDA Permission For Covid-19 Antibody Test
Vancouver’s Victory Square Health acquired Brazilian Covid19 test developers Safetest in June. Today Safetest was granted permission by the Food & Drug Administration (FDA) in the United States to commence marketing, sales and distribution under the emergency use authorization (EUA) for its Safetest Covid-19 assay for detecting the virus causing Covid-19. Safetest Covid-19 IgG /IgM […]
Victory Square Acquires 15 Minute Covid-19 Antibody Test
Vancouver’s Victory Square Health has acquired Brazilian Covid19 test developers, Safetest. The portfolio company of Victory Square Technologies acquired Safetest Comércio de Diagnósticos’s assets and intellectual property in an all-stock transaction valued at $4 million. Safetest was founded in 2016 to bring high quality rapid tests to the market and has developed antibody-based tests and […]